Background/Aims: Bone resorption mediated by osteoclasts plays an important role in bone healing. Endothelial progenitor cells (EPCs) promote bone repair by stimulating neovascularization and osteogenesis. However, the role of EPCs in osteoclast formation and function is not well defined. The aim of this study was to elucidate mechanisms of EPCs in osteoclast formation and function. Methods: In this study, we examined the effects of EPCs on the proliferation, migration and osteoclastic differentiation of primary mouse bone marrowderived macrophages (BMMs) in a co-culture system in vitro. We also evaluated the effects of EPC co-transplantation on the homing and osteoclastic differentiation of transplanted BMMs in a mouse bone fracture model in vivo. The technology of immunofluorescence, immunohistochemical, western blot, Rt-PCR, cell co-culture and Transwell were used in this study. Results: EPCs secreted TGF-β1 in the EPC-BMM co-culture medium and increased Talin-1 expression in the co-cultured BMMs. Treatment with a TGF-β1 neutralizing antibody or Talin-1 silencing in BMMs completely inhibited BMM osteoclastic differentiation in the co-culture system. These results indicated that the osteoclastogenic effects of EPCs were mediated by TGF-β1-mediated Talin-1 expression in BMMs. In the femur fracture model, BMMs co-transplanted with EPCs exhibited enhanced engraftment into the fracture site and osteoclastic differentiation compared with those transplanted alone. Mice treated with EPC-BMM co-transplantation exhibited increased neovascularization at the fracture site and accelerated fracture healing compared with those treated with BMMs alone. Conclusion: Taken
Introduction
Bone is one of the few tissues/organs that can undergo complete regeneration after injury [1] . Bone healing occurs through the coordinated activities of osteoclasts and osteoblasts to achieve site-directed removal of damaged bone by osteoclasts and subsequent bone formation by osteoblasts to replace the bone loss [2] . Osteoclasts are highly specialized, multinucleated cells that are derived from hematopoietic precursors of the monocyte-macrophage lineage residing in the bone marrow [3] . Osteoclast formation (osteoclastogenesis) depends on two essential cytokines: RANKL (receptor activator of nuclear factor (NF)-κB ligand) and M-CSF (macrophage colony-stimulating factor). RANKL, a tumor necrosis factor (TNF) family cytokine, directly controls osteoclast differentiation through activation of TNF receptor-associated factor (TRAF) 6, NF-κB (nuclear factor kappalight-chain-enhancer of activated B cells) and c-Fos [4] . M-CSF supports the survival and proliferation of the osteoclast precursor cells [5, 6] through activation of Mitf and Bcl-2 [7, 8] . The full differentiation and activation of osteoclasts require several additional signals that argument RANKL or M-CSF signaling [9] . For instance, TGF-b has been reported to promote RANKL-induced osteoclastogenesis through SMAD2/SMAD3 [10] , and β3 integrins have been shown to regulate the differentiation and function of osteoclasts in concert with M-CSF [11, 12] .
Endothelial progenitor cells (EPCs) give rise to functional endothelial cells to sustain vasculogenesis. They home to sites of vascular injury to engage in angiogenesis during the process of tissue remodeling and regeneration [13] . EPCs can promote neovascularization of tissue-engineered bones, and further improve osteogenesis and bone reconstruction [14] [15] [16] . In addition, they can stimulate osteoblastic differentiation in vitro [17] and accelerate fracture healing in a segmental bone defect model in vivo [18] . Emerging evidence suggests that EPCs may also play a role in osteoclast formation and function. Specifically, EPCs have been reported to support the survival, migration, and differentiation of RAW 264.7 cells, a model of osteoclastic monocyte precursors, through multiple signaling pathways [19, 20] . However, whether EPCs can influence osteoclastogenesis by bone marrow-derived macrophages (BMMs) is not clear.
b3 integrin signaling is a well-known mechanism regulating the formation and activity of osteoclasts [12, 21] . Integrins use numerous cytosolic integrin-associated proteins (IAPs) to mediate their functions. Talin is the most important IAP that links b integrins directly to actin, increasing the affinity of integrin for ligands and activating downstream events [22] . Studies have shown that Talin-1 plays a critical in the motility and bone resorption of osteoblasts [23, 24] . In this study, we investigated the role of EPCs in the survival, migration and osteoclastic differentiation of BMMs in vitro. We also evaluated the effects of EPC cotransplantation on the homing and osteoclastic differentiation of transplanted BMMs in a mouse bone fracture model in vivo. The underlying molecular mechanisms involving TGF-b and Talin-1 were examined.
Materials and Methods

Animals
Six-week-old C57BL/10 mice were purchased from the Model Animal Research Center (MARC) of Nanjing University. All animal experiments were performed in accordance with the Institutional Guidelines for the Care and Use of Laboratory Animals of the Southwest Hospital, affiliated with the Third Military Medical University. All study protocols were reviewed and approved by the Animal Ethics Committee of the Southwest Hospital.
Isolation and characterization of EPCs
Mononuclear cells were isolated from mouse umbilical cord blood. Cells expressing the early EPC surface marker CD133 were selected using anti-CD133-coupled magnetic microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany) and expanded in Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Immunophenotypic analysis was performed by staining 5×10 5 cells with monoclonal antibodies against CD31, CD34, CD133, vWF, and UFA-1, respectively (Sigma, St. Louis, MO, USA). Isotype-identical antibodies served as controls (PharMingen, San Diego, CA, USA). All cells were counterstained with the carbocyanine fluorescent dye Dil (Molecular Probes, Eugene, OR, USA). The angiogenic capacity of the early EPCs was determined by the Matrigel tube formation assay as we previously reported [19] . In brief, Matrigel (Sigma) was diluted in 500 μl EGM-2 media (1:1 v/v) in 96-well plates and incubated at 37°C for 1 h to allow polymerization. EPCs (2×10 4 cells/well) were seeded onto the Matrigel and incubated at 37°C for 24 h. Digital micrographs were taken for morphological analysis.
BMM isolation and differentiation
Mouse primary BMMs were prepared as previously described [24] with minor modifications. In brief, marrow was extracted from femora and tibiae of six-week-old C57BL/10 mice with α-minimal essential medium (α-MEM) and placed in Petri dishes in a culture medium composed of α-MEM supplemented with 10% inactivated fetal bovine serum (FBS), 100 IU/ml penicillin and 100 mg/ml streptomycin and CMG medium (conditioned medium containing 100 ng/ml mouse M-CSF) in a 1:10 ratio. Cells were incubated at 37°C with 5% CO 2 for 3 days, washed with phosphate-buffered saline (PBS) and harvested with trypsin/ EDTA (Invitrogen, Carlsbad, CA, USA).
To test the effects of EPCs on the proliferation and osteoclastic differentiation of BMMs, a co-culture system was established by inserting transwell chambers with 3 μm pores (Millipore, Bedford, MA, USA) pre-seeded with EPCs (1×10 3 cells/chamber) into 12-well culture plates pre-seeded with BMMs (1×10 3 cells/well). DMEM (1 ml/well) was subsequently added to cover both the EPCs and BMMs to allow crosstalk between the two cell types. Half of the medium was removed and replaced with fresh medium every two days. Cell proliferation was determined using the Cell Counting Kit-8 (CCK-8) assay. Osteoclastic differentiation was assessed by immunofluorescence staining for the osteoclast marker TRAP (tartrate acid resistant phosphatase) using anti-TRAP antibody (Sigma-Aldrich, St. Louis, MO, USA). BMMs cultured in medium containing GST-RANKL (100 ng/ml) and M-CSF (30 ng/ml) served as positive control for osteoclastic differentiation. TGF-β1 levels in culture supernatants were determined by ELISA (Sigma-Aldrich, St. Louis, MO, USA). To test the effects of TGF-β1 inhibition, cells were cultured in medium containing a neutralizing antibody toward TGF-β1 (Sigma).
Transwell migration assay
The migration capacity of BMMs was measured using transwell inserts with a pore size of 8 μm (Costar, Corning, NY). In brief, BMMs were loaded into the upper chamber and EPCs into the lower chamber. After incubation at 37°C with 5% CO 2 for 5 days, the BMMs were rinsed with PBS, fixed in 10% formalin for 10 min, and stained with DAPI for 15 min. The cells that had migrated to the lower surface of the membrane were counted in three randomly selected fields under an inverted light microscope (Leica, Germany) as previously described [25] .
RNA interference
BMMs were collected and resuspended in Electroporation Isoosmolar Buffer (Eppendorf). The cells were transfected using electroporation with a Stealth RNAi™ small interfering RNA (siRNA) targeting Talin-1 (sense sequence: CAGCUCAUUGCUGGCUACAUAGAUA, Invitrogen) or a Stealth RNAi™ siRNA negative control (Med GC) on an ECM830 Electro-Square Porator (Harvard Apparatus). The electroporation was carried out using a single square wave pulse of 2, 500 V/cm field strength with 300 μs pulse length. After that, the cells were allowed to recover for 46 h in DMEM.
Western blot analysis
Cells were lysed and total proteins were quantified. Samples (30-50 μg each) were separated by 10% SDS-PAGE (stacking gel 50 V, separating gel 100 V) and transferred to nitrocellulose membranes (100 V for 75 min). After blocking in defatted milk for 2 h, the membranes were incubated with primary antibodies followed by horse radish peroxidase (HRP)-conjugated secondary antibodies. The protein bands were visualized using enhanced chemiluminescence. Densitometry analysis of protein levels was performed using Gel-pro Image Analysis Software (Media cybernetics, Rockville, MD, USA).
Preparation of green fluorescent protein (GFP)-labeled EPCs
EPCs were seeded in 24-well plates (5×10 4 cells/well) and cultured until they reached 70% confluence. The cells were subsequently incubated with lentiviral vectors expressing GFP (Invitrogen) at a multiplicity of infection (MOI) of 20. The medium was replaced after 24 h, and the fluorescence intensity was recorded after 96 h. Uninfected EPCs served as negative control.
Femur fracture model
All surgical procedures were performed under normal aseptic conditions. Mice were anesthetized with intraperitoneal ketamine hydrochloride (60 mg/kg) and xylazine hydrochloride (10mg/kg). Femur fractures (unilateral) were produced by 3-point bending using the method described by Manigrasso [26] . Unfractured femurs served as negative control. Immediately after the fracture, mice received intravenous injection of BMMs (2×10 5 cells) suspended in Endothelial Basal Medium-2 (EBM-2, Lonza), either alone or in combination with GFP-labeled EPCs (2×10 5 cells). To detect BMM homing to the fracture site, the cells were labeled with Dil (Molecular Probes) at 2.5 mg/ml for 5 min at 37°C followed by another 15 min at 4°C just before transplantation. To assess angiogenesis by EPCs, tissue samples were collected from the fracture site on day 7 or day 28 after cell transplantation, embedded in OCT compound (Sakura Finetek Japan, Tokyo, Japan), snap-frozen in liquid nitrogen and cut into 5-μm-thick sections. The sections were stained with anti-CD31 antibody (Vector Laboratories, Burlingame, CA, USA), counterstained with DAPI, and examined under a fluorescence microscope. Dil-positive capillaries were counted in 10 randomly selected high-power fields. Talin-1 expression in BMMs was detected by immunofluorescence staining with anti-Talin-1 antibody (Vector Laboratories, Burlingame, CA, USA).
Microcomputed tomography (μCT)
The trabecular volumes at the distal femoral metaphysis and proximal tibia were determined using a Scanco CT40 scanner (Scanco Medical AG, Bassersdorf, Switzerland; threshold = 250). Forty to 100 slices were analyzed, starting with the first slice in which condyles and primary spongiosa were no longer visible.
Quantitative real-time PCR analysis
RNA was isolated from BMMs or bone tissues using TRIZOL (Invitrogen). cDNA was synthesized from 1 μg of total RNA in 21-μl reaction volumes using oligo dT18 primers and SuperScript reverse transcriptase. PCR amplification was carried out with Taq DNA polymerase (TaKaRa) using 1 μl of the first-strand cDNAs as templates. The amplification reactions were run with 30 thermocycles of 30 s at 94°C, 30 s at 55°C and 30 s at 72°C. The primer sequences were: Car2, 5'-CATTACTGTCAGCAGCGAGCA-3' (sense) and 5'-GACGCCAGTTGTCCACCATC-3' (anti-sense); CTSK, 5'-CAGCAGAACGGAGGCATTGA-3' (sense) and 5'-CCTTTGCCGTGGCGTTATAC-3' (anti-sense); MMP9, 5'-GCCCTGGAACTCACACGACA-3' (sense) and 5'-TTGGAAACTCACACGCCAGAA-3' (anti-sense); TRAP, 5'-CAGTTGGCAGCAGCCAAGGAGGAC-3' (sense) and 5'-GTCCCTCAGGAGTCTAGGTATCAC-3' (anti-sense); GAPDH, 5'-CACAGTCAAGGCCGAGAATG-3' (sense) and 5'-TCGTGGTTCACACCCATCAC-3' (anti-sense).
Statistical analysis
All data are reported as the mean ± SD. The Student's two-tailed unpaired t-test was applied to interpret differences between two groups. A p value less than 0.05 was regarded as statistically significant.
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Results
EPCs enhance the proliferation, migration and osteoclastic differentiation of co-cultured BMMs
The CD133 + cells isolated from mouse umbilical cord blood exhibited a spindle-like morphology (Fig. 1A) and expressed a spectrum of EPC-specific surface markers including CD31, CD34, CD133, Flk-1, VEGFR2, vWF and UFA-1 (Fig. 1B-H) . These cells also showed angiogenic potential as they formed tube-like structures on Matrigel (Fig. 1I) . Compared with BMMs cultured alone, BMMs co-cultured with EPCs exhibited significantly increased cell proliferation and migration capacity ( Fig. 2A-D) . We subsequently assessed osteoclastic differentiation of BMMs by immunofluorescence staining for the osteoclast marker TRAP [27] . We found that co-culture with EPCs greatly enhanced the differentiation of BMMs into TRAP-positive multinucleated osteoclast-like cells, although the osteoclastogenic activity of EPCs was less potent compared with RANKL plus M-SCF (Fig. 3A, B) .
EPCs enhance osteoclastic differentiation of co-cultured BMMs through TGF-β1-mediated
Talin-1 signaling ELISA revealed increased TGF-b1 level in the EPC-BMM co-culture supernatant compared with BMM culture alone (Fig. 4A) . Blocking TGF-b1 signaling with a TGF-b1 neutralizing antibody inhibited the differentiation of the co-cultured BMMs into TRAPpositive multinucleated osteoclast-like cells (Fig. 4B, C) . Western blot analysis detected 
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increased Talin-1 expression in the co-cultured BMMs compared with BMMs cultured alone, and incubation with the TGF-b1 neutralizing antibody blocked Talin-1 expression in the cocultured BMMs (Fig. 4D ). Similar to treatment with the TGF-b1 neutralizing antibody, Talin-1 knockdown by siRNA transfection in BMMs prevented the osteoclastic differentiation of the co-cultured BMMs (Fig. 4E, F) . The result show that compared with control or negative control (NC). The expression of Talin-1 was signifigantly decreased in both protein and mRNA level (Fig. 5) . In addition, compared with BMMs cultured alone, BMMs co-cultured with EPCs exhibited increased mRNA and protein expression of the osteoclast genes MMP9, CTSK, TRAP, and Car2, and treatment with the TGF-b1 neutralizing antibody or Talin-1 knockdown prevented the expression of these osteoclast genes ( Fig. 6A-E) . Collectively, these data indicated that EPCs promote osteoclastic differentiation of the co-cultured BMMs through TGF-β1 secretion and consequent upregulation of BMM Talin-1 expression.
EPC co-transplantation promotes the homing and osteoclastic differentiation of BMMs, and further accelerates bone healing
Four weeks after cell transplantation, femur fractures treated with Dil-labeled BMMs along with GFP-labeled EPCs exhibited better bone healing than those treated with Dillabeled BMMs alone (Fig. 7A) . Transplantation of BMMs alone led to partial fracture repair, while BMM-EPC co-transplantation resulted in formation of continuous new bone that covered the entire fracture area. Seven days after transplantation, mice treated with BMM-EPC co-transplantation showed a greater number of Dil-labeled BMMs with higher Talin-1 expression around the fracture site than those treated with BMM transplantation alone (Fig. Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry 7B), indicating that EPC co-transplantation promoted the homing of the transplanted BMMs to the injury site and stimulated Talin-1 expression in engrafted cells. The BMM-EPC cotransplantation group also exhibited increased CD31 immunofluorescence at the fracture site 4 weeks after transplantation, especially in areas where GFP-labeled EPCs were detected (Fig. 7C) . Interestingly, significant amounts of engrafted BMMs were detected around newlyformed capillaries at the fracture site in both treatment groups, with a higher density of such capillaries observed in the BMM-EPC co-transplantation group (Fig. 7D ). These data suggested that the engrafted BMMs directly enhanced neovascularization at the fracture site by paracrine mechanisms. In keeping with our in vitro data, mice treated with BMM-EPC co-transplantation showed higher mRNA levels of TGF-β1 and the osteoclast genes MMP9, TRAP and CTSK at the fracture site than those treated with BMM transplantation alone ( Fig.  7E-H) .
Discussion
In animal models, EPCs have been shown to promote bone repair through a variety of mechanisms, by differentiating into endothelial cells and osteoblasts to enhance neovascularization and osteogenesis, as well as stimulating supporting cells by paracrine mechanisms through the secretion of growth factors and cytokines [28, 29] . They have also been reported to enhance osteogenic differentiation capacities of osteoblast precursors in vitro and in vivo [17, 30] . With regard to the role of EPCs in osteoclast formation and function, previous reports have shown that EPCs support the survival, migration, and differentiation of RAW 264.7 cells, a model of osteoclastic monocyte precursors [19, 20] . In this study, we found that EPCs derived from mouse umbilical cord blood promoted the proliferation, migration and osteoclastic differentiation of primary mouse BMMs in a EPC-BMM coculture system. In keeping with these in vitro results, co-transplantation of EPCs enhanced the homing and osteoclastic differentiation of transplanted BMMs in a mouse femur fracture model, and further accelerated fracture healing.
TGF-b has been documented to regulate osteoclastogenesis by activating Smad2/3 [10] . In Pang's report [19] , EPCs secreted VEGF-A, SDF-1 and TGF-b1 in the EPC-RAW 264.7 coculture system and increased levels of phospho-Smad2/3, phospho-Akt, phospho-ERK1, and phospho-p38 MAPK in the co-cultured RAW 264.7 cells. These data supported the TGF-b1-Smad2/3 signaling pathway as a potential mediator of the osteoclastogenic effects of EPCs on the co-cultured RAW 264.7. In this study, EPCs secreted TGF-b1 in the EPC-BMM co-culture system, and the osteoclastogenic effects of EPCs on the co-cultured BMMs were completely blocked by treatment with a TGF-b1 neutralizing antibody. Taken together, these findings strongly suggest that EPCs stimulate differentiation of surrounding osteoclast precursors by paracrine mechanisms through the secretion of TGF-b1.
Talin-1 is a fundamental protein component of the osteoclast cytoskeleton, and as such plays a critical role in the adhesion, motility and bone resorption of osteoblasts [23, 24] . We found that EPCs increased Talin-1 expression in the co-cultured BMMs through a TGFb1-depedent mechanism, and similar to TGF-b1 neutralizing antibody treatment, Talin-1 silencing in BMMs completed prevented osteoclastic differentiation of BMMs co-cultured with EPCs. Thus, Talin-1 acts downstream of TGF-b1 in mediating the osteoclastogenic effects of EPCs. The molecular mechanisms by which TGF-b1 increases Talin-1 expression in BMMs are currently unclear, and thus, require further investigation.
In the femur fracture model, BMMs co-transplanted with EPCs exhibited enhanced engraftment into the fracture site and osteoclastic differentiation compared with those transplanted alone. Co-transplantation of BMMs and EPCs also led to increased neovascularization at the injury site compared with BMM transplantation alone. We believe that the accelerated fracture healing achieved by the co-transplantation therapy was attributed to increased neovascularization as well as enhanced osteoclastic activity at the injury site.
Phase I/IIa clinical trials applying granulocyte colony stimulating factor-mobilized EPCs to nonunion bone fractures have generated accelerated fracture healing with minimal adverse effects [31] . Our findings shed new light on the mechanisms by which EPCs promote bone repair and support EPC-based therapy in orthopaedics.
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